Light Therapy Treatment

An exemplary method includes selecting at least one light source configured to generate light at a particular wavelength and applying the light to tissue following an ischemic event. Applying the light to the tissue inhibits cytochrome c oxidase activity. Another exemplary method includes selecting at least one light source configured to generate light at a particular wavelength and applying the light to tissue following an ischemic event and prior to either reoxygenation of the tissue or clinical intervention to reduce cell damage. An exemplary light therapy device includes at least one light source configured to generate light having a wavelength of at least one of approximately 730-770 nm, 850-890 nm, 880-920 run, and 930-970 nm.

Attached files:


Patents:
WO 2,010,127,249

Inventor(s): HUTTEMANN MAIK [US]; DOAN JEFFREY [US]; GROSSMAN LAWRENCE [US]; KAMHOLZ JOHN [US]; LEE ICKSOO [US]; PRZYKLENK KARIN [US]; SANDER

Type of Offer: Licensing



« More Medical Patents

---